Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Falko Fend

Showing results (341-350 of 399) with videos related to

Pageof 40
Sort By:
Oncoimmunology|April 14, 2017
HLA class I-restricted <i>MYD88</i> L265P-derived peptides as specific targets for lymphoma immunotherapyAnnika Nelde, Juliane Sarah Walz, Daniel Johannes Kowalewski, et al.
Leukemia|March 24, 2026
CD70/CD27 signaling promotes the pathogenesis of multiple myeloma and represents a promising therapeutic targetStefan Forster, Chantal Reinhardt, Maxime Boy, et al.
Blood Advances|October 15, 2021
Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangementsLeonie Frauenfeld, Natalia Castrejon-de-Anta, Joan Enric Ramis-Zaldivar, et al.
The American Journal of Surgical Pathology|May 14, 2015
Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinomaKarl-Friedrich Deml, Hans-Ulrich Schildhaus, Eva Compérat, et al.
Blood|May 24, 2017
Mutations of <i>MAP2K1</i> are frequent in pediatric-type follicular lymphoma and result in ERK pathway activationJanine Schmidt, Joan Enric Ramis-Zaldivar, Ferran Nadeu, et al.
Nature Communications|December 2, 2021
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancerClemens Hinterleitner, Jasmin Strähle, Elke Malenke, et al.
Leukemia|November 28, 2020
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphomaCosimo Lobello, Boris Tichy, Vojtech Bystry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapyGunter von Minckwitz, Berit Maria Müller, Sibylle Loibl, et al.
Diagnostics (Basel, Switzerland)|February 10, 2024
Optical Emission Spectroscopy for the Real-Time Identification of Malignant Breast TissueSelin Guergan, Bettina Boeer, Regina Fugunt, et al.
Archives of Gynecology and Obstetrics|December 23, 2017
Selecting living donors for uterus transplantation: lessons learned from two transplantations resulting in menstrual functionality and another attempt, aborted after organ retrievalSara Y Brucker, Mats Brännström, Florin-Andrei Taran, et al.
Pageof 40

Showing results (341-350 of 399) with videos related to

Sort By:
Pageof 40
Oncoimmunology|April 14, 2017
HLA class I-restricted <i>MYD88</i> L265P-derived peptides as specific targets for lymphoma immunotherapyAnnika Nelde, Juliane Sarah Walz, Daniel Johannes Kowalewski, et al.
Leukemia|March 24, 2026
CD70/CD27 signaling promotes the pathogenesis of multiple myeloma and represents a promising therapeutic targetStefan Forster, Chantal Reinhardt, Maxime Boy, et al.
Blood Advances|October 15, 2021
Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangementsLeonie Frauenfeld, Natalia Castrejon-de-Anta, Joan Enric Ramis-Zaldivar, et al.
The American Journal of Surgical Pathology|May 14, 2015
Clear cell papillary renal cell carcinoma and renal angiomyoadenomatous tumor: two variants of a morphologic, immunohistochemical, and genetic distinct entity of renal cell carcinomaKarl-Friedrich Deml, Hans-Ulrich Schildhaus, Eva Compérat, et al.
Blood|May 24, 2017
Mutations of <i>MAP2K1</i> are frequent in pediatric-type follicular lymphoma and result in ERK pathway activationJanine Schmidt, Joan Enric Ramis-Zaldivar, Ferran Nadeu, et al.
Nature Communications|December 2, 2021
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancerClemens Hinterleitner, Jasmin Strähle, Elke Malenke, et al.
Leukemia|November 28, 2020
STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphomaCosimo Lobello, Boris Tichy, Vojtech Bystry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapyGunter von Minckwitz, Berit Maria Müller, Sibylle Loibl, et al.
Diagnostics (Basel, Switzerland)|February 10, 2024
Optical Emission Spectroscopy for the Real-Time Identification of Malignant Breast TissueSelin Guergan, Bettina Boeer, Regina Fugunt, et al.
Archives of Gynecology and Obstetrics|December 23, 2017
Selecting living donors for uterus transplantation: lessons learned from two transplantations resulting in menstrual functionality and another attempt, aborted after organ retrievalSara Y Brucker, Mats Brännström, Florin-Andrei Taran, et al.
Pageof 40